Abstract
To find new anti-cancer drug therapies, we wanted to exploit homeostatic vulnerabilities within Tuberous Sclerosis Complex 2 (TSC2)-deficient cells wi......
小提示:本篇文献需要登录阅读全文,点击跳转登录